Dr. Mark E. Kalina, MD

Dr. Kalina practices at Scripps Clinic OB-GYN La Jolla Campus in La Jolla, California.

Dr. Kalina's NPI, 1275638801, was assigned on September 14, 2006. Dr. Kalina graduated from Cleveland Medical College, Homeopathic in 1989. Dr. Kalina holds California license A49274.

Dr. Kalina's primary practice is Scripps Clinic OB-GYN La Jolla Campus, at 9850 Genesee Ave, La Jolla, CA 92037 in San Diego County. The practice phone is (858) 453-0753.

Dr. Kalina's primary practice is Scripps Clinic OB-GYN La Jolla Campus in La Jolla, California. The medical group on file is Perlman Clinic. Dmand AI also links Dr. Kalina to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalina practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kalina's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kalina is board certified in internal medicine by the American Board of Internal Medicine. Dr. Kalina is licensed in California.

Dmand AI lists acute kidney failure, acute skin infection, aneurysm, anxiety, atrial fibrillation and flutter, bursitis, chronic diabetes and chronic hypertension among the conditions Dr. Kalina treats.

CMS data shows 594 Medicare services from Dr. Kalina across 10 procedure codes in 2024, for 224 Medicare patients. Medicare paid $51,372 for them. Every service was in an office.

CMS counts 224 Medicare patients who saw Dr. Kalina in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 9% are also on Medicaid. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kalina's median patient age at 71, with 49% women.

In 2024, Dr. Kalina wrote 5,965 Medicare Part D claims for 734 patients. 88% of them were for generic drugs. CMS names the drug for 5,159 of them, across 114 drugs with 11 or more claims each, at $343,080 in total drug cost. In 2023, CMS named 3,221 claims across 83 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Kalina for performance year 2024, reported as part of a group. Dr. Kalina accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kalina as offering telehealth.

Dmand AI links 3 papers to Dr. Kalina, published from 2020 to 2021. 2020 was the busiest year, with 2. Dr. Kalina has published most often in Trauma Surg Acute Care Open. Dr. Kalina's most frequent co-authors are Christopher David Flanagan, MD, Noah Michael Joseph and Trenton Rivera, MD.

CMS Open Payments shows 167 general payments to Dr. Kalina from 39 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $718.

Dr. Kalina graduated from Cleveland Medical College, Homeopathic in 1989.

Dr. Kalina is in network with 8 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.